← Biofrontera Inc.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Net Income From Continuing Operations | ($11.0m) | ($37.7m) | ($640k) | ($20.1m) | ($17.8m) | ($10.5m) | ($11.1m) | |
| Net loss | ($11.0m) | ($37.7m) | ($640k) | ($20.1m) | ($17.8m) | ($10.5m) | — | |
| Depreciation, Depletion and Amortization | — | — | $754k | $646k | $600k | $138k | $836k | |
| Depreciation | $144k | $122k | $101k | $86k | $92k | $100k | $836k | |
| Amortization of Intangible Assets | $418k | $418k | $418k | $418k | $329k | — | — | |
| Amortization Cash Flow | — | $418k | $418k | $418k | $329k | — | — | |
| Amortization Of Intangibles | — | $418k | $418k | $418k | $329k | — | $16k | |
| Depreciation Amortization Depletion | — | — | $1.2m | $1.1m | $1.1m | $868k | $836k | |
| Share-based Payment Arrangement, Noncash Expense | — | $129k | $1.9m | $1.0m | $1.0m | $951k | $1.1m | |
| Stock-Based Compensation Expense | — | $129k | $1.9m | $1.0m | $1.0m | $951k | $1.1m | |
| Gain (Loss) on Sale of Assets and Asset Impairment Charges | — | — | — | — | — | $700k | — | |
| Impairment of Intangible Assets, Finite-lived | — | — | — | — | — | $0 | — | |
| Income (Loss) from Equity Method Investments | — | — | $1.7m | ($7.4m) | ($14k) | $2k | — | |
| Other Nonoperating Income (Expense) | $1.6m | $689k | $33k | ($75k) | $158k | $388k | — | |
| Nonoperating Income (Expense) | ($1.3m) | ($12.5m) | $18.0m | $2.6m | ($527k) | $837k | — | |
| Changes in operating assets and liabilities: | ||||||||
| Change In Working Capital | — | — | $2.8m | ($4.4m) | $6.2m | ($3.5m) | $217k | |
| Increase (Decrease) in Accounts Receivable | ($1.2m) | $612k | $70k | $1.5m | $315k | $1.9m | $177k | |
| Accounts receivable | $1.2m | ($612k) | ($70k) | ($1.5m) | ($315k) | ($1.9m) | $177k | |
| Other receivables, related party | — | ($11.4m) | $5.0m | $6.5m | $2k | — | — | |
| Change In Receivables | — | — | $4.9m | $4.9m | ($313k) | ($1.9m) | $177k | |
| Changes In Account Receivables | — | — | ($70k) | ($1.5m) | ($315k) | ($1.9m) | $177k | |
| Increase (Decrease) in Inventories | $273k | ($2.6m) | $2.8m | $3.8m | ($4.2m) | ($1.4m) | $1.6m | |
| Inventory Write-down | $401k | $33k | $100k | — | — | — | — | |
| Inventories | ($273k) | $2.6m | ($2.8m) | ($3.8m) | $4.2m | $1.4m | $1.6m | |
| Change In Inventory | — | — | ($2.8m) | ($3.8m) | $4.2m | $1.4m | $1.6m | |
| Change in Accounts Payable | ($3.4m) | ($773k) | $912k | ($6.4m) | ($230k) | $610k | — | |
| Accounts payable, related parties, net | — | — | — | $4.4m | ($355k) | ($533k) | ($1.0m) | |
| Change In Payables And Accrued Expense | — | — | ($2.7m) | $64k | ($2.0m) | $75k | ($1.0m) | |
| Change In Accrued Expense | — | — | ($3.6m) | ($6.4m) | ($230k) | $610k | $869k | |
| Prepaid expenses and other assets | $364k | ($3.8m) | $4.2m | $174k | ($141k) | ($1.7m) | — | |
| Other assets, related party | — | — | — | ($5.2m) | $5.2m | ($686k) | — | |
| Change In Other Current Assets | — | — | $0 | ($5.2m) | $5.2m | ($686k) | ($661k) | |
| Change In Other Current Liabilities | — | — | ($781k) | ($657k) | ($689k) | ($683k) | ($514k) | |
| Net Cash Provided by (Used in) Operating Activities | ($12.4m) |
($26.7m)
-115.98%
|
($16.2m)
+39.36%
|
($24.9m)
-53.68%
|
($10.3m)
+58.75%
|
($13.4m)
-30.10%
|
($9.3m)
+30.29%
|
|
| Cash flows from investing activities: | ||||||||
| Payments to Acquire Property, Plant, and Equipment | — | ($11k) | ($38k) | $5k | $10k | $2k | ($4k) | |
| Gain (Loss) on Investments | — | — | $1.7m | ($7.4m) | ($14k) | $2k | ($134k) | |
| Net Cash from Investing Activities | — | — | — | $624k | $57k | — | — | |
| Net Cash Provided by (Used in) Investing Activities | — | ($11k) | ($5.2m) | $619k | ($3k) | $3.0m | $3.0m | |
| Cash flows from financing activities: | ||||||||
| Gain (Loss) on Extinguishment of Debt | — | — | — | — | ($316k) | — | — | |
| Issuance Of Debt | — | $0 | $0 | $25.2m | $4.0m | — | $7.9m | |
| Long Term Debt Issuance | — | $0 | $0 | $21.4m | — | — | $7.9m | |
| Net Issuance Payments Of Debt | — | — | $0 | $3.9m | ($265k) | $0 | $0 | |
| Net Short Term Debt Issuance | — | — | $0 | $3.9m | ($265k) | $0 | $0 | |
| Short Term Debt Issuance | — | — | $0 | $25.2m | $4.0m | — | $4.0m | |
| Payment of principal short-term debt | — | — | — | ($21.3m) | ($4.3m) | — | — | |
| Repayment Of Debt | — | — | — | ($21.3m) | ($4.3m) | $0 | $0 | |
| Short Term Debt Payments | — | — | — | ($21.3m) | ($4.3m) | $0 | $0 | |
| Issuance Of Capital Stock | — | — | $9.4m | $4.5m | $7.7m | $10.8m | $10.8m | |
| Proceeds from Issuance of Common Stock | — | $14.9m | — | — | — | — | $0 | |
| Common Stock Issuance | — | $29.9m | $9.4m | $4.5m | $0 | — | $0 | |
| Net Cash Provided by (Used in) Financing Activities | $13.2m |
$43.2m
+227.35%
|
$14.0m
-67.54%
|
$8.4m
-40.01%
|
$14.8m
+76.38%
|
$10.8m
-26.86%
|
$10.8m
0.00%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $825k | $16.5m | ($7.3m) | ($15.9m) | $4.6m | $487k | $6.5m | |
| Beginning Cash Position | — | — | $24.7m | $17.4m | $1.5m | $6.1m | $2.0m | |
| Cash, cash equivalents and restricted cash, at the beginning of the year | $8.3m | $24.7m | $17.4m | $1.5m | $6.1m | $6.6m | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $8.3m | $24.7m | $17.4m | $1.5m | $6.1m | $6.6m | $6.5m | |
| Additional Supplementary Disclosures | ||||||||
| Additional Supplementary Disclosures | ||||||||
| Income Tax Expense (Benefit) | $64k | $56k | $32k | $14k | $22k | $25k | — | |
| Non-cash interest expense | $358k | $358k | $358k | $402k | $297k | $491k | — | |
| Operating lease liabilities | — | — | ($781k) | ($657k) | ($689k) | ($683k) | — | |
| Interest Expense | — | $2k | $1k | $125k | $1.7m | $6k | — | |
| Income Tax Expense | $64k | $56k | $32k | $15k | $24k | $25k | — | |
| Additional Financial Items | ||||||||
| Asset Acquisition Contingent Consideration Liability | $7.6m | $6.2m | $2.4m | — | — | — | — | |
| Equity Securities, FV-NI, Gain (Loss) | — | — | — | ($7.4m) | ($14k) | — | — | |
| Equity Securities, FV-NI, Realized Gain (Loss) | — | — | — | $7.2m | $98k | — | — | |
| Equity Securities, FV-NI, Unrealized Gain (Loss) | — | — | — | ($202k) | ($84k) | — | — | |
| Gain (Loss) Related to Litigation Settlement | — | — | — | $7.4m | — | — | — | |
| General and Administrative Expense | — | — | — | — | $16.3m | $22.9m | — | |
| Investment Income, Interest | $28k | $16k | — | — | $71k | — | — | |
| Operating Expenses | $28.5m | $49.3m | $47.3m | $56.7m | — | $53.1m | — | |
| Restructuring Costs | $1.1m | $800k | $0 | — | — | — | — | |
| Provision for Doubtful Accounts (CF) | ($16k) | $44k | $106k | $122k | $162k | ($69k) | — | |
| Realized/unrealized loss in investment, related party | — | — | ($1.7m) | $7.4m | $14k | ($2k) | — | |
| Cash flows provided by (used in) investing activities | — | ($11k) | ($5.2m) | $619k | ($3k) | $3.0m | — | |
| Proceeds from issuance of Series B-1 preferred stock and warrants to purchase series B-3 preferred stock, net of issuance costs | — | — | $9.4m | $4.5m | $7.7m | — | — | |
| Cash flows provided by financing activities | $13.2m | $43.2m | $14.0m | $8.4m | $14.8m | $10.8m | — | |
| Cash Flow From Continuing Financing Activities | — | — | $14.0m | $8.4m | $14.8m | $10.8m | $10.8m | |
| Cash Flow From Continuing Investing Activities | — | — | ($5.2m) | $619k | ($3k) | $3.0m | $3.0m | |
| Change In Account Payable | — | ($773k) | — | $6.4m | ($1.8m) | ($535k) | ($1.0m) | |
| Change In Payable | — | — | $912k | $6.4m | ($1.8m) | ($535k) | ($1.0m) | |
| Change In Prepaid Assets | — | — | $4.2m | $174k | ($141k) | ($1.7m) | ($285k) | |
| Changes In Cash | — | — | ($7.3m) | ($15.9m) | $4.6m | $487k | $4.5m | |
| End Cash Position | — | — | $17.4m | $1.5m | $6.1m | $6.6m | $6.5m | |
| Financing Cash Flow | — | — | $14.0m |
$8.4m
-40.01%
|
$14.8m
+76.38%
|
$10.8m
-26.86%
|
$10.8m
0.00%
|
|
| Free Cash Flow | — | — | ($16.2m) | ($24.9m) | ($10.3m) | ($13.4m) | ($9.3m) | |
| Gain Loss On Investment Securities | — | — | ($16.4m) | $4.3m | ($1.7m) | ($901k) | ($134k) | |
| Gain Loss On Sale Of PPE | — | — | — | — | $0 | ($700k) | ($700k) | |
| Investing Cash Flow | — | — | ($5.2m) | $619k | ($3k) | $3.0m | $3.0m | |
| Net Intangibles Purchase And Sale | — | — | — | $0 | ($50k) | $0 | $0 | |
| Net PPE Purchase And Sale | — | — | ($38k) | ($5k) | ($10k) | ($2k) | ($4k) | |
| Net Preferred Stock Issuance | — | — | — | $0 | $7.7m | $10.8m | $10.8m | |
| Operating Gains Losses | — | — | ($16.4m) | $4.3m | ($1.4m) | ($1.6m) | ($834k) | |
| Other Non Cash Items | — | — | ($3.4m) | ($6.9m) | $297k | $510k | — | |
| Proceeds From Stock Option Exercised | — | — | $4.6m | $0 | $7.4m | $0 | $0 | |
| Provisionand Write Offof Assets | — | — | $206k | $122k | $162k | ($69k) | ($24k) | |
| Purchase Of Intangibles | — | — | — | $0 | ($50k) | $0 | $0 | |
| Purchase Of PPE | — | — | ($38k) | ($5k) | ($10k) | ($2k) | ($4k) | |
| Stock Based Compensation | — | — | $1.9m | $1.0m | $1.0m | $951k | $1.1m | |
| Unrealized Gain Loss On Investment Securities | — | $0 | ($1.7m) | $7.4m | — | — | — | |
| Net Investment Purchase And Sale | — | — | ($5.1m) | $624k | $57k | $0 | $0 | |
| Purchase Of Investment | — | $0 | ($5.1m) | $0 | — | — | $0 | |
| Sale Of Investment | — | — | $0 | $624k | $57k | $0 | $0 | |
| Net increase in cash and cash equivalents | $825k | $16.5m | ($7.3m) | ($15.9m) | $4.6m | $487k | — | |
| Supplemental disclosure of cash flow information: | ||||||||
| Change In Cash Supplemental As Reported | — | — | ($7.3m) | ($15.9m) | $4.6m | $487k | — | |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | $2k | $1k | $125k | $1.7m | $6k | — |